Ayalon Insurance Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.8M Buy
+55,600
New +$7.52M 1.08% 24
2022
Q3
Sell
-19,320
Closed -$1.44M 111
2022
Q2
$1.44M Buy
+19,320
New +$1.45M 0.68% 38
2022
Q1
Sell
-2,350
Closed -$263K 142
2021
Q4
$263K Hold
2,350
0.09% 96
2021
Q3
$296K Sell
2,350
-4,034
-63% -$519K 0.11% 93
2021
Q2
$884K Sell
6,384
-6,130
-49% -$806K 0.29% 72
2021
Q1
$1.72M Buy
12,514
+15
+0.1% +$2.25K 0.67% 47
2020
Q4
$1.76M Hold
12,499
0.8% 38
2020
Q3
$1.4M Sell
12,499
-2,950
-19% -$331K 0.77% 36
2020
Q2
$1.74M Buy
15,449
+14,780
+2,209% +$1.46M 1.01% 31
2020
Q1
$49K Hold
669
0.04% 95
2019
Q4
$64K Sell
669
-84
-11% -$7.27K 0.04% 100
2019
Q3
$56K Sell
753
-595
-44% -$49.4K 0.04% 103
2019
Q2
$119K Hold
1,348
0.08% 71
2019
Q1
$122K Sell
1,348
-150
-10% -$12.8K 0.09% 66
2018
Q4
$107K Sell
1,498
-12,447
-89% -$1M 0.09% 67
2018
Q3
$1.3M Sell
13,945
-10,550
-43% -$1.02M 1.04% 28
2018
Q2
$2.33M Buy
24,495
+8,295
+51% +$762K 1.95% 14
2018
Q1
$1.42M Buy
16,200
+400
+3% +$36.5K 1.18% 22
2017
Q4
$1.34M Buy
+15,800
New +$1.32M 1.09% 20

Other funds holding XBI

Ayalon Insurance Company's XBI Position: Q2 2026 in Review

Ayalon Insurance Company opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 55,600 shares worth $8.8M. The stake represents 1.08% of the portfolio and ranks #24 among its holdings. This is a return to the name: Ayalon Insurance Company previously reported a position in XBI as recently as Q2 2022.

Ayalon Insurance Company first reported a position in XBI in Q4 2017 and has held it in 19 quarters since. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Ayalon Insurance Company held 55,600 shares of State Street SPDR S&P Biotech ETF worth $8.8M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Ayalon Insurance Company position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 1.08% of Ayalon Insurance Company's portfolio in Q2 2026, its #24 holding.
  • Ayalon Insurance Company first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 19 quarters since.
  • 393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Ayalon Insurance Company's 13F filing for Q2 2026, filed 13 Jul 2026.